featured
OncoSupport for Oncocardiology Prescribing
Written by
Written by
Sign in to PracticeUpdate
Only registered members have full access to PracticeUpdate content.
Additional Info
- Kovacs RJ, Burris HA 3rd. Cardio-oncology: stronger together. JACC CardioOncol. 2019;1(1):133-134.
- Jacobse JN, Schaapveld M, Boekel NB, et al. Risk of heart failure after systemic treatment for early breast cancer: results of a cohort study. Breast Cancer Res Treat. 2021;185(1):205-214.
- Woosley RL, Black K, Heise CW, Romero K. CredibleMeds.org: What does it offer? Trends Cardiovasc Med. 2018;28(2):94-99.
- Salem JE, Nguyen LS, Moslehi JJ, et al. Anticancer drug-induced life-threatening ventricular arrhythmias: a World Health Organization pharmacovigilance study. Eur Heart J. Published online August 9, 2021. doi:10.1093/eurheartj/ehab362
- Ye JZ, Hansen FB, Mills RW, Lundby A. Oncotherapeutic protein kinase inhibitors associated with pro-arrhythmic liability. JACC CardioOncol. 2021;3(1):88-97.
- Lehmann LH, Totzeck M. Establishing an oncocardiology service. Herz. 2020;45(7):626-631.
- Woosley RL, Heise CW, Gallo T, Tate J, Woosley DR, Romero KA. Accessed September 1, 2021.
- Woosley RL, Simmons J, Sefilyan EM, Atkins S, Black K, Read WA. Linking technology to address the social and medical determinants of health for safe medicines use. J Patient Saf. Published online June 5, 2021. doi:10.1097/PTS.0000000000000876